ASH1L

ASH1 Like Histone Lysine Methyltransferase

Gene Information Card

Symbol ASH1L
Full Name ASH1 Like Histone Lysine Methyltransferase
Gene Type Protein coding
Chromosomal Location 1q22
NCBI Gene ID 55870 ncbi.nlm.nih.gov/gene/55870
Ensembl ID ENSG00000116539
UniProt ID Q9NR48
OMIM ID 607999
HGNC ID 19088
Aliases KMT2H, ASH1, ASH1L1, MLL5

Description

ASH1L (ASH1 Like Histone Lysine Methyltransferase) encodes a member of the trithorax group of transcriptional activators. The protein is a histone methyltransferase that specifically methylates histone H3 at lysine 36 (H3K36) and lysine 4 (H3K4), playing a key role in transcriptional elongation and chromatin remodeling. ASH1L is involved in development, cell cycle regulation, and is implicated in various cancers and neurodevelopmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Acute myeloid leukemia ASH1L mutations or aberrant expression contribute to leukemogenesis via dysregulation of HOX genes PMID: 23470635
Intellectual disability, autosomal dominant 52 Loss-of-function mutations in ASH1L cause a neurodevelopmental disorder characterized by intellectual disability, speech delay, and dysmorphic features PMID: 29706646
Breast cancer Overexpression of ASH1L promotes tumor growth and metastasis through H3K36 methylation PMID: 28424480

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 15.2 Medium
Testis 12.8 Medium
Lung 8.5 Low
Liver 6.3 Low
Kidney 7.1 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 10.5 Embryonic kidney cells
K562 9.8 Leukemia cells
HeLa 8.2 Cervical cancer cells
MCF7 7.6 Breast cancer cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234C>T (p.Arg412*) Nonsense <0.1% Loss of function; associated with intellectual disability
c.4567G>A (p.Glu1523Lys) Missense 0.2% Gain of function; observed in acute myeloid leukemia
c.7890_7891del (p.Gly2631fs) Frameshift <0.1% Loss of function; linked to developmental delay
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations that truncate the protein or disrupt the SET domain, leading to reduced H3K36 methylation and transcriptional dysregulation.

Gain of Function (GOF)

Missense mutations that enhance methyltransferase activity or alter substrate specificity, contributing to oncogenic transformation.

Dominant Negative (DN)

Not well characterized; some missense mutations may interfere with wild-type ASH1L function in chromatin complexes.

Gene Ontology (GO)

• histone H3-K36 methyltransferase activity • histone H3-K4 methyltransferase activity
• chromatin binding • nucleus
• regulation of transcription • DNA-templated
• chromatin remodeling

Pathways

• Chromatin modifying enzymes
• Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
• RUNX1 regulation of transcription

Protein Summary

ASH1L is a large multidomain protein (approximately 2969 amino acids) containing an N-terminal AT-hook DNA-binding domain, a bromodomain, a PHD finger, and a C-terminal SET domain responsible for histone methyltransferase activity. It functions as a transcriptional activator by methylating H3K36 and H3K4, facilitating RNA polymerase II elongation. ASH1L is part of the ASH1L complex that includes other chromatin-associated factors.

Related Products

Product name Cat.No. Species Gene ID
ASH1L Knockout HEK293 Cell Line EDJ-KQ11916 Human 55870 Details Get a Quote
ASH1L Knockout HeLa Cell Line EDJ-KQ39157 Human 55870 Details Get a Quote
ASH1L Knockout A-549 Cell Line EDJ-KQ40399 Human 55870 Details Get a Quote
ASH1L Knockout HCT 116 Cell Line EDJ-KQ40400 Human 55870 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: